Sun to Receive Shares from Cellebrite Following Price Adjustment

MT Newswires Live11-12

Sun (TYO:6736) said it will receive 3.5 million shares of Cellebrite DI, its equity-method affiliate, following the fulfillment of a price adjustment clause, according to a Monday filing on the Tokyo Stock Exchange.

Cellebrite's shares, which rose to $12.5 on Aug. 14, $15 on Sept. 13, and $17.5 on Nov. 1, met the conditions outlined in a reverse triangular merger agreement from April 2021.

Under the agreement, Cellebrite will issue up to 15 million shares in compensation if specific price thresholds are met over five years. The shares are being issued free of charge, with no change to SunCorporation's operating income projection.

Price (JPY): $8040.00, Change: $-30, Percent Change: -0.37%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment